A 24 –month observational study to evaluate the safety of Lucentis™ (0.5mg) in a cohort of patients with choroidal neovascularization secondary to age-related macular degeneration

Hdl Handle:
http://hdl.handle.net/10147/198689
Title:
A 24 –month observational study to evaluate the safety of Lucentis™ (0.5mg) in a cohort of patients with choroidal neovascularization secondary to age-related macular degeneration
Issue Date:
22-Dec-2011
URI:
http://hdl.handle.net/10147/198689
Keywords:
SAFETY; OLDER PEOPLE
Local subject classification:
MACULAR DEGENERATION
Ethical Approval:
Yes
Start Date:
2009-03
Principal Investigator:
Woods, Christopher

Full metadata record

DC FieldValue Language
dc.date.accessioned2011-12-22T14:25:19Z-
dc.date.available2011-12-22T14:25:19Z-
dc.date.issued2011-12-22T14:25:19Z-
dc.identifier.urihttp://hdl.handle.net/10147/198689-
dc.subjectSAFETYen
dc.subjectOLDER PEOPLEen
dc.subject.otherMACULAR DEGENERATIONen
dc.titleA 24 –month observational study to evaluate the safety of Lucentis™ (0.5mg) in a cohort of patients with choroidal neovascularization secondary to age-related macular degenerationen
dc.type.qualificationlevelN/Aen
cr.approval.ethicalYesen
cr.contributor.principalWoods, Christopheren
cr.date.start2009-03-
dc.description.provinceLeinster-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.